Tcg Crossover Management, LLC: holdings and changes
Number 19 of the top 100 funds by copy return. Tcg Crossover Management, LLC reported 57 US stocks worth $3.5B for the quarter ending 2026-09-30 and changed 8 new, 3 added, 14 trimmed and 5 sold since 2026-06-30.
Copy return, 4 quarters+64.4%
US 500, same time+14.5%
Size$3.5B
Stocks57
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| ABVX Abivax Sa-Adr | TRIM -39% | 10.25% | $363M | 3,663,038 |
| CGON Cg Oncology INC | 7.35% | $260M | 3,670,206 | |
| AMLX Amylyx Pharmaceuticals INC Com | 5.13% | $182M | 6,243,812 | |
| AEGLEA BIOTHER Aeglea Biotherapeutics INC | 4.78% | $169M | 1,900,582 | |
| TNGX Tango Therapeutics INC | TRIM -25% | 4.77% | $169M | 6,773,043 |
| ZLAB Zai Lab Limited Adr | 4.64% | $164M | 6,229,081 | |
| IMVT Immunovant INC | 4.25% | $151M | 4,457,988 | |
| DNTH Dianthus Therapeutics INC | 4.17% | $148M | 1,676,624 | |
| KRSA Korsana Biosciences INC | BUY | 4.11% | $146M | 4,549,587 |
| KOD Kodiak Sciences INC | 3.87% | $137M | 1,445,538 | |
| VOR Vor Biopharma INC | 3.06% | $108M | 5,673,078 | |
| TRAX First Tracks Biotherapeutics | 2.90% | $103M | 2,895,304 | |
| MIRM Mirum Pharmaceuticals, INC. | ADD +5% | 2.70% | $96M | 1,118,967 |
| BCRX Biocryst Pharmaceuticals INC | 2.59% | $92M | 11,020,968 | |
| IRON Disc Medicine INC | 2.48% | $88M | 1,341,862 | |
| ADRX Adarx Pharmaceuticals INC | BUY | 2.32% | $82M | 4,116,452 |
| COGT Cogent Biosciences INC | TRIM -49% | 2.26% | $80M | 2,500,003 |
| TYRA Tyra Biosciences INC | ADD +7% | 2.15% | $76M | 3,475,980 |
| DYN Dyne Therapeutics INC | 2.10% | $74M | 4,615,144 | |
| RLAY Relay Therapeutics INC | TRIM -11% | 1.93% | $68M | 3,783,529 |
| AURA Aura Biosciences INC | ADD +7% | 1.80% | $64M | 10,165,357 |
| SVRA Savara INC | 1.80% | $64M | 12,362,205 | |
| XNCR Xencor INC | TRIM -16% | 1.45% | $51M | 2,055,938 |
| AVTX Avalo Therapeutics INC | 1.31% | $46M | 3,017,120 | |
| GLUE Monte Rosa Therapeutics INC | TRIM -18% | 1.27% | $45M | 3,781,532 |
| MBX Mbx Biosciences INC | 1.08% | $38M | 650,000 | |
| ENTX Entera Bio LTD | BUY | 1.01% | $36M | 12,254,901 |
| JANX Janux Therapeutics INC. | 0.87% | $31M | 1,789,617 | |
| TARS Tarsus Pharmaceuticals INC | BUY | 0.86% | $30M | 388,164 |
| IPSC Century Therapeutics INC | 0.86% | $30M | 17,754,430 | |
| OBX Obsidian Therapeutics INC | BUY | 0.85% | $30M | 2,196,138 |
| PHVS Pharvaris N V | TRIM -6% | 0.85% | $30M | 947,544 |
| LBRX Lb Pharmaceuticals INC | TRIM -47% | 0.83% | $29M | 765,050 |
| EDIT Editas Medicine INC | 0.81% | $29M | 11,111,111 | |
| TECX Tectonic Therapeutic INC | 0.79% | $28M | 1,204,891 | |
| IFRX Inflarx Nv | 0.74% | $26M | 14,500,000 | |
| CATX Perspective Therapeutics INC | 0.61% | $22M | 7,915,567 | |
| AGMB Agomab Therapeutics Nv | TRIM -11% | 0.57% | $20M | 1,820,831 |
| SLN Silence Therapeutics PLC | TRIM -40% | 0.56% | $20M | 1,819,035 |
| ALEC Alector INC Com | 0.52% | $18M | 10,000,000 | |
| BHVN Biohaven LTD | TRIM -29% | 0.48% | $17M | 1,262,423 |
| MNPR Monopar Therapeutics INC | 0.46% | $16M | 202,242 | |
| ADCT Adc Therapeutics Sa | 0.39% | $14M | 11,390,175 | |
| TRDA Entrada Therapeutics, INC. | 0.19% | $7M | 1,060,230 | |
| CULLINAN ONCOL Cullinan Oncology INC | 0.18% | $6M | 406,786 | |
| AGEN Agenus INC Com New | BUY | 0.17% | $6M | 603,892 |
| OCUL Ocular Therapeutix INC | TRIM -56% | 0.16% | $6M | 720,323 |
| ARVN Arvinas INC | 0.15% | $6M | 707,098 | |
| KRRO Korro Bio INC | 0.12% | $4M | 416,301 | |
| RACD Research Alliance Corp Iv | BUY | 0.10% | $4M | 300,000 |
| ALXO Alx Oncology Holdings INC | TRIM -56% | 0.10% | $3M | 2,465,436 |
| AKTS Aktis Oncology INC | TRIM -81% | 0.07% | $3M | 133,457 |
| JATT Jatt II Acquisition Corp | 0.06% | $2M | 200,000 | |
| ATHIRA PHARMA Athira Pharma INC | 0.05% | $2M | 464,398 | |
| JTTT Jatt III Acquisition Corp | BUY | 0.03% | $1M | 100,000 |
| CNTX Context Therapeutics INC | 0.02% | $800k | 2,682,696 | |
| EIKN Eikon Therapeutics INC | 0.01% | $300k | 37,902 | |
| RVMD Revolution Medicines INC | SELL | 0% | was $64M | 0 |
| SRZN Surrozen INC | SELL | 0% | was $38M | 0 |
| ALT Altimmune INC | SELL | 0% | was $30M | 0 |
| FORTE BIOSCIEN Forte Bioscience INC | SELL | 0% | was $20M | 0 |
| RACC Research Alliance Corp III | SELL | 0% | was $5M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2022-12-31 → 2023-03-31 | -0.7% | +7.0% |
| 2023-03-31 → 2023-06-30 | +23.7% | +8.3% |
| 2023-12-31 → 2024-03-31 | +27.9% | +10.0% |
| 2024-06-30 → 2024-09-30 | +17.6% | +5.4% |
| 2024-09-30 → 2024-12-31 | -22.3% | +2.1% |
| 2024-12-31 → 2025-03-31 | -25.9% | -4.6% |
| 2025-03-31 → 2025-06-30 | +28.8% | +10.5% |
| 2025-06-30 → 2025-09-30 | +71.6% | +7.8% |
| 2025-09-30 → 2025-12-31 | +38.8% | +2.4% |
| 2025-12-31 → 2026-03-31 | +8.8% | -4.6% |
| 2026-03-31 → 2026-06-30 | +21.6% | +14.8% |
| 2026-06-30 → 2026-09-30 | -10.5% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP